Reaction to this week's political shocks, why many conservatives are choosing to double down on Trump critics, and then, a conversation on the growing dis-union in America.
An FDA advisory board recommended withdrawing government approval for the breast cancer drug, Avastin. Pros and cons of the decision and its implications for FDA’s accelerated approval process to treat serious and life threatening diseases.
- Gardiner Harris Science reporter for "The New York Times" and author of the mystery novel 'Hazard.'
- Dr. Carolyn Hendricks A medical oncologist affiliated with Suburban Hospital in Bethesda.
- William Hubbard Former associate commissioner for the Food and Drug Administration; spokesperson for the Alliance for a Stronger FDA
- Dr. Peter Bach Attending physician and director of the Center for Health Policy and Outcomes at Memorial Sloan-Kettering Cancer Center, and a former adviser to Medicare.
Most Recent Shows
Political fallout from the dismissal of FBI director James Comey, how our government created racially segregated cities, and a young Palestinian's perspective on Mideast peace.
Washington Post reporter Dan Balz on covering President Trump and linguist Deborah Tannen on how women support each other with the words they use.
American University history professor Allan Lichtman describes how and why President Donald Trump could be impeached, and then, Pulitzer Prize winning writer Elizabeth Strout on her new book, "Anything is Possible".